期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
4-羟基他莫昔芬通过抑制DNMT1/DNMT3A表达逆转三阴性乳腺癌细胞间质表型
1
作者 王一丁 汪茜 《转化医学杂志》 2020年第2期88-91,100,共5页
目的探讨4-羟基他莫昔芬(4-hydroxytamoxifen,4-OHT)能否通过上调微小RNA-200c(microRNA-200c,miR-200c)表达抑制DNA甲基化转移酶(DNA methyltransferase,DNMT)1和DNMT3A,从而逆转三阴性乳腺癌(triple negative breast cancer,TNBC)细... 目的探讨4-羟基他莫昔芬(4-hydroxytamoxifen,4-OHT)能否通过上调微小RNA-200c(microRNA-200c,miR-200c)表达抑制DNA甲基化转移酶(DNA methyltransferase,DNMT)1和DNMT3A,从而逆转三阴性乳腺癌(triple negative breast cancer,TNBC)细胞间质表型。方法采用Western Blot检测雌激素受体-α(estrogen receptor-α,ER-α)、孕激素受体(progesterone receptor,PR)及人表皮生长因子受体-2(human epidermal growth factor receptor-2,HER-2),DNMT1,DNMT3A,Vimentin和Actin蛋白的表达。采用实时荧光定量PCR技术检测miR-200c的相对表达量。应用网络数据库及在线分析软件预测miR-200c启动子的CpG岛。结果不同表型乳腺癌细胞miR-200c表达差异显著;4-OHT上调TNBC细胞miR-200c表达;miR-200c启动子存在CpG岛;4-OHT能够上调miR-200c影响DNMT1/DNMT3A表达。结论TNBC细胞miR-200c表达降低,4-OHT能够上调TNBC细胞中miR-200c表达。4-OHT通过上调间质样TNBC细胞miR-200c表达,抑制DNMT1、DNMT3A表达,从而逆转间质样表达。 展开更多
关键词 三阴性乳腺癌 甲基化转移酶 4-羟基他莫昔芬 MicroRNA-200c
下载PDF
A stringent dual control system overseeing transcription and activity of the Cre recombinase for the liver-specific conditional gene knock-out mouse model 被引量:3
2
作者 Yu Wu Yinghua He +5 位作者 Hongyu Zhang Xinlan Dai Xiaoyu Zhou Jun Gu Guan Wang Jingde Zhu 《Journal of Genetics and Genomics》 SCIE CAS CSCD 北大核心 2008年第7期431-439,共9页
Liver cancer is one of the most threatening diseases in Chinese population. Just like in other tissues, tumor initiation and development in liver involve multiple steps of genetic and epigenetic alterations with sever... Liver cancer is one of the most threatening diseases in Chinese population. Just like in other tissues, tumor initiation and development in liver involve multiple steps of genetic and epigenetic alterations with several unknown details. However, unlike in other tissues, a tissue specific inducible Cre recombinase system that allows temporal and spatial deletion of a target DNA fragment is still not available for in vivo functional gene annotation in hepatocytes. In our pursuit to establish such a mouse model, we designed a dual inducible Cre transgene system and tested it in cultured cells. By combining a CCAAT/enhancer binding protein β (C/EBP β) promoter derived Tet-off expression system and the estrogen receptor (ER) mediated functional control, we show a desirable profile of both hepatocyte-specificity and regulability of the Cre expression in a series of critical assessments in the cell culture system, which provides confidence in continuation of our ongoing pursuit in mouse. 展开更多
关键词 Cre/loxP TET-OFF hepatocyte-specific DOXYCYCLINE 4-oht C/EBβ
下载PDF
离线紫外照射和高效液相荧光法测定他莫昔芬及代谢物在人血浆中的浓度 被引量:2
3
作者 朱余兵 张倩 +3 位作者 于翠霞 邹建军 卢弢 肖大伟 《中国药学杂志》 CAS CSCD 北大核心 2009年第21期1658-1661,共4页
目的建立高效液相荧光法测定人血浆中他莫昔芬及主要代谢物浓度。方法血浆样品经正己烷-正丁醇(98∶2)提取后,以甲醇-1%三乙胺水溶液(82∶18)为流动相,流速为1mL·min-1,色谱柱为Agilent Extend C18(4.6mm×150mm,5μm),... 目的建立高效液相荧光法测定人血浆中他莫昔芬及主要代谢物浓度。方法血浆样品经正己烷-正丁醇(98∶2)提取后,以甲醇-1%三乙胺水溶液(82∶18)为流动相,流速为1mL·min-1,色谱柱为Agilent Extend C18(4.6mm×150mm,5μm),柱温为50℃,离线紫外照射(254nm)10.5min,使目标化合物转变成强荧光性的菲衍生物,荧光检测波长:激发波长(λex)260nm,发射波长(λem)375nm。结果血浆内源性杂质不干扰待测物测定,线性范围分别为:他莫昔芬为0.5~200μg·L-1;N-去甲他莫昔芬为0.5~300μg·L-1;4-羟基他莫昔芬为0.1~10μg·L-1。日内、日间精密度(RSD)均小于10%。样品4次冻融,以及在提取后,4℃下12h内稳定性良好。结论该法灵敏、快速、准确,操作简便、线性范围宽,可用于他莫昔芬的药动学研究及常规治疗药物监测。 展开更多
关键词 他莫昔芬 N-去甲他莫昔芬 4-羟基他莫昔芬 高效液相荧光法
原文传递
Targeting hormone-resistant breast cancer cells with docetaxel:a look inside the resistance
4
作者 Alexander M.Scherbakov Anna A.Basharina +5 位作者 Danila V.Sorokin Ekaterina I.Mikhaevich Iman E.Mizaeva Alexandra L.Mikhaylova Tatiana A.Bogush Mikhail A.Krasil’nikov 《Cancer Drug Resistance》 2023年第1期103-115,共13页
Aim:The study aims to analyze the effect of long-term incubation of ERα-positive MCF7 breast cancer cells with 4-hydroxytamoxifen(HT)on their sensitivity to tubulin polymerization inhibitor docetaxel.Methods:The anal... Aim:The study aims to analyze the effect of long-term incubation of ERα-positive MCF7 breast cancer cells with 4-hydroxytamoxifen(HT)on their sensitivity to tubulin polymerization inhibitor docetaxel.Methods:The analysis of cell viability was performed by the MTT method.The expression of signaling proteins was analyzed by immunoblotting and flow cytometry.ERαactivity was evaluated by gene reporter assay.To establish hormone-resistant subline MCF7,breast cancer cells were treated with 4-hydroxytamoxifen for 12 months.Results:The developed MCF7/HT subline has lost sensitivity to 4-hydroxytamoxifen,and the resistance index was 2.Increased Akt activity(2.2-fold)and decreased ERαexpression(1.5-fold)were revealed in MCF7/HT cells.The activity of the estrogen receptorαwas reduced(1.5-fold)in MCF7/HT.Evaluation of class Ⅲβ-tubulin expression(TUBB3),a marker associated with metastasis,revealed the following trends:higher expression of TUBB3 was detected in triple-negative breast cancer MDA-MB-231 cells compared to hormone-responsive MCF7 cells(P<0.05).The lowest expression of TUBB3 was found in hormone-resistant MCF7/HT cells(MCF7/HT<MCF7<MDA-MB-231,approximately 1:2:4).High TUBB3 expression strongly correlated with docetaxel resistance:IC_(50)value of docetaxel for MDA-MB-231 cells was greater than that for MCF7 cells,whereas resistant MCF7/HT cells were the most sensitive to the drug.The accumulation of cleaved PARP(a 1.6-fold increase)and Bcl-2 downregulation(1.8-fold)were more pronounced in docetaxel-treated resistant cells(P<0.05).The expression of cyclin D1 decreased(2.8-fold)only in resistant cells after 4 nM docetaxel treatment,while this marker was unchanged in parental MCF7 breast cancer cells.Conclusion:Further development of taxane-based chemotherapy for hormone-resistant cancer looks highly promising,especially for cancers with low TUBB3 expression. 展开更多
关键词 Cancer DOCETAXEL 4-hydroxytamoxifen classⅢβ-tubulin RESISTANCE breast cancer estrogen receptors alpha
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部